Tecfidera multiple sclerosis drug

Tecfidera multiple sclerosis drug

C029/2154 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 65.0MB

Downloadable file size: 7.8MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Tecfidera multiple sclerosis drug. Capsule of the drug Tecfidera (dimethyl fumarate), taken twice daily in the treatment of relapsing remitting multiple sclerosis. Tecfidera was approved for use in the USA in 2013, and in Europe in 2014. Multiple sclerosis is a progressive disorder in which the body's immune system attacks the myelin sheaths that cover nerve fibres. It can cause tingling, speech disorders, lack of coordination, paralysis and death.

Release details: Model release not required. Property release not required.

Keywords: 1, 2016, 21st century, biogen idec, british, capsule, capsules, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, dimethyl fumarate, drug, gastro-resistant hard capsules, healthcare, medical, medicine, multiple sclerosis, no-one, nobody, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pill pills, relapsing remitting multiple sclerosis, single, studio shot, tecfidera, treatment, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.